Pan-cancer analysis of the prognostic and immunological role of PSMB8
Open Access
- 14 October 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-19
Abstract
Recently some evidence has demonstrated the significance of PSMB8 in various malignancies. Nevertheless, PSMB8 (proteasome subunit beta 8), more familiar in the field of immunology contributing to the process of antigen presentation, is indeterminate in the role as a survival predictor of human pan-cancer. Besides, how PSMB8 interacts with immune cell infiltration in the tumor microenvironment requires further research. We then penetrated into the analysis of the PSMB8 expression profile among 33 types of cancer in the TCGA database. The results show that overexpression of PSMB8 was associated with poor clinical outcomes in overall survival (Sartorius et al. in Oncogene 35(22):2881–2892, 2016), disease-specific survival (DSS), disease-free interval (DFI), and progression-free interval (PFI) in most cancer varieties. In addition, there existed distinctly positive correlations between PSMB8 and immunity, reflected straightforwardly in the form of immune scores, tumor-infiltrating immune cells (TIICs) abundance, microsatellite instability, tumor mutation burden, and neoantigen level. Notably, specific markers of dendrite cells exhibited the tightest association with PSMB8 expression in terms of tumor-related immune infiltration patterns. Moreover, gene enrichment analysis showed that elevated PSMB8 expression was related to multiple immune-related pathways. We finally validated the PSMB8 expression in our local breast samples via quantitative PCR assays and concluded that PSMB8 appeared to perform well in predicting the survival outcome of BRCA patients. These findings elucidate the pivotal role of the antigen presentation-related gene PSMB8, which could potentially serve as a robust biomarker for prognosis determination in multiple cancers.Keywords
Funding Information
- Science and Technology Plan Project of Wenzhou Municipality (Y20180848, Y20180848, Y20180848, Y20180848, Y20180848, Y20180848)
- Major Science and Technology Projects of Zhejiang Province (2015C03052, 2015C03052, 2015C03052)
- Scientific Research Incubator Project of The First Affiliated Hospital of Wenzhou Medical University (FHY2019060)
This publication has 22 references indexed in Scilit:
- Pembrolizumab as Second-Line Therapy for Advanced Urothelial CarcinomaNew England Journal of Medicine, 2017
- Epigenomic Deconvolution of Breast Tumors Reveals Metabolic Coupling between Constituent Cell TypesCell Reports, 2016
- BPTF Depletion Enhances T-cell–Mediated Antitumor ImmunityCancer Research, 2016
- Expression of immunoproteasome genes is regulated by cell-intrinsic and –extrinsic factors in human cancersScientific Reports, 2016
- Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanismOncogene, 2015
- Immune and non-immune functions of the immunoproteasomeFrontiers in Bioscience-Landmark, 2012
- Different Expression Levels of the TAP Peptide Transporter Lead to Recognition of Different Antigenic Peptides by Tumor-Specific CTLThe Journal of Immunology, 2011
- Towards a systems understanding of MHC class I and MHC class II antigen presentationNature Reviews Immunology, 2011
- PSMB8 Encoding the β5i Proteasome Subunit Is Mutated in Joint Contractures, Muscle Atrophy, Microcytic Anemia, and Panniculitis-Induced Lipodystrophy SyndromeThe American Journal of Human Genetics, 2010
- Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunityBlood, 2007